PROLONG PHARMACEUTICALS JOINS NEW SICKLE CELL DISEASE COALITION, ISSUES CALL TO ACTION TO IMPROVE TREATMENT AND CARE

Prolong Pharmaceuticals joins other leading patient advocacy groups, researchers, clinicians, policymakers, industry, and foundations in a collective effort to improve sickle cell disease (SCD) care, early diagnosis, treatment, and research, both in the United States and globally...